Levine Cancer Institute Concord

Concord, North Carolina 28205

1 studies enrolling now · 5 studies all time

What they study most

Follicular Lymphoma, HER2-positive Breast Cancer, Multiple Myeloma, Pancreatic Cancer, Refractory Follicular Lymphoma, Relapsed/Refractory Follicular Lymphoma, Urothelial Carcinoma

Studies at this site

• A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2 — Recruiting now
• A Study to Assess the Efficacy, Safety, Pharmacodynamics, and Pharmacokinetics of Tazemetostat in Combination With Lenalidomide Plus Rituximab Versus Placebo in Combination With Lenalidomide Plus Rituximab in Adult Patients at Least 18 Years of Age With Relapsed/Refractory Follicular Lymphoma. — Running, not enrolling
• A Study of Tucatinib vs. Placebo in Combination With Ado-trastuzumab Emtansine (T-DM1) for Patients With Advanced or Metastatic HER2+ Breast Cancer — Running, not enrolling
• A Study of Modakafusp Alfa on Adult Participants With Relapsed/Refractory Multiple Myeloma — Stopped early
• A Study of Regorafenib in Advanced Pancreatic Cancer Patients — Completed